Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Personalized Real-Time DBS and PD Mechanisms

NCT: NCT06013956 · RECRUITING

NCT IDNCT06013956
StatusRECRUITING
Start Date2023-08-29
Completion2028-06-30

Brief Summary

A prospective cohort of patients scheduled to undergo deep brain stimulation (DBS) implantation surgery for the treatment of Parkinson's disease as per standard of care will be invited to participate in this study. This mechanistic study is aimed at better understanding the role of basal ganglia beta band (11-35 Hz) oscillations and resonance in the manifestation of Parkinson's disease (PD) motor signs using closed-loop electrical neurostimulation, levodopa medication, and computational modeling. The ultimate goal of this study is to inform the development of closed-loop neuromodulation technology that can be programmed and adjusted in real time based on patient-specific neural activity.

Frequently Asked Questions

What is Personalized Real-Time DBS and PD Mechanisms?

Personalized Real-Time DBS and PD Mechanisms is a clinical trial registered under NCT06013956. Current status: RECRUITING.

What is the status of NCT06013956?

The current status of NCT06013956 (Personalized Real-Time DBS and PD Mechanisms) is: RECRUITING.

When did Personalized Real-Time DBS and PD Mechanisms start?

Personalized Real-Time DBS and PD Mechanisms started on 2023-08-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.